Report Details

Tables and Figures
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radiopharmaceuticals in Nuclear Medical Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Radiopharmaceuticals in Nuclear Medical Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2021)
Table 10. Global Market Radiopharmaceuticals in Nuclear Medical Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Radiopharmaceuticals in Nuclear Medical Sales Sites and Area Served
Table 12. Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
Table 13. Global Radiopharmaceuticals in Nuclear Medical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Radiopharmaceuticals in Nuclear Medical
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceuticals in Nuclear Medical Market Challenges
Table 22. Market Restraints
Table 23. Global Radiopharmaceuticals in Nuclear Medical Sales by Type (K Units)
Table 24. Global Radiopharmaceuticals in Nuclear Medical Market Size by Type (M USD)
Table 25. Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) by Type (2017-2022)
Table 26. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2017-2022)
Table 27. Global Radiopharmaceuticals in Nuclear Medical Market Size (M USD) by Type (2017-2022)
Table 28. Global Radiopharmaceuticals in Nuclear Medical Market Size Share by Type (2017-2022)
Table 29. Global Radiopharmaceuticals in Nuclear Medical Price (USD/Unit) by Type (2017-2022)
Table 30. Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) by Application
Table 31. Global Radiopharmaceuticals in Nuclear Medical Market Size by Application
Table 32. Global Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2022) & (K Units)
Table 33. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2017-2022)
Table 34. Global Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2022) & (M USD)
Table 35. Global Radiopharmaceuticals in Nuclear Medical Market Share by Application (2017-2022)
Table 36. Global Radiopharmaceuticals in Nuclear Medical Sales Growth Rate by Application (2017-2022)
Table 37. Global Radiopharmaceuticals in Nuclear Medical Sales by Region (2017-2022) & (K Units)
Table 38. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2017-2022)
Table 39. North America Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2022) & (K Units)
Table 40. Europe Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Region (2017-2022) & (K Units)
Table 42. South America Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Region (2017-2022) & (K Units)
Table 44. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Basic Information
Table 45. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Overview
Table 46. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Bracco Imaging Business Overview
Table 48. Bracco Imaging Radiopharmaceuticals in Nuclear Medical SWOT Analysis
Table 49. Bracco Imaging Recent Developments
Table 50. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Basic Information
Table 51. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Overview
Table 52. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Cambridge Isotope Laboratories Business Overview
Table 54. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical SWOT Analysis
Table 55. Cambridge Isotope Laboratories Recent Developments
Table 56. Cardinal Health Radiopharmaceuticals in Nuclear Medical Basic Information
Table 57. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Overview
Table 58. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K Units), Market Size (M USD), Price
(USD/Unit) and Gross Margin (2017-2022)
Table 59. Cardinal Health Business Overview
Table 60. Cardinal Health Radiopharmaceuticals in Nuclear Medical SWOT Analysis
Table 61. Cardinal Health Recent Developments
Table 62. Medtronic Radiopharmaceuticals in Nuclear Medical Basic Information
Table 63. Medtronic Radiopharmaceuticals in Nuclear Medical Product Overview
Table 64. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Medtronic Business Overview
Table 66. Medtronic Radiopharmaceuticals in Nuclear Medical SWOT Analysis
Table 67. Medtronic Recent Developments
Table 68. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Basic Information
Table 69. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Overview
Table 70. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Eczacibasi-Monrol Business Overview
Table 72. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical SWOT Analysis
Table 73. Eczacibasi-Monrol Recent Developments
Table 74. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Basic Information
Table 75. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Overview
Table 76. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Fujifilm Holdings Corporation Business Overview
Table 78. Fujifilm Holdings Corporation Recent Developments
Table 79. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Basic Information
Table 80. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Overview
Table 81. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. GE Healthcare (Subsidiary Of General Electric Company) Business Overview
Table 83. GE Healthcare (Subsidiary Of General Electric Company) Recent Developments
Table 84. IBA Group Radiopharmaceuticals in Nuclear Medical Basic Information
Table 85. IBA Group Radiopharmaceuticals in Nuclear Medical Product Overview
Table 86. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. IBA Group Business Overview
Table 88. IBA Group Recent Developments
Table 89. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Basic Information
Table 90. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Overview
Table 91. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Lantheus Medical Imaging Business Overview
Table 93. Lantheus Medical Imaging Recent Developments
Table 94. Nordion Radiopharmaceuticals in Nuclear Medical Basic Information
Table 95. Nordion Radiopharmaceuticals in Nuclear Medical Product Overview
Table 96. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Nordion Business Overview
Table 98. Nordion Recent Developments
Table 99. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Basic Information
Table 100. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Overview
Table 101. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Ntp Radioisotopes Business Overview
Table 103. Ntp Radioisotopes Recent Developments
Table 104. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Basic Information
Table 105. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Overview
Table 106. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Siemens Healthcare Business Overview
Table 108. Siemens Healthcare Recent Developments
Table 109. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Basic Information
Table 110. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Overview
Table 111. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Taiyo Nippon Sanso Corporation Business Overview
Table 113. Taiyo Nippon Sanso Corporation Recent Developments
Table 114. Urenco Limited Radiopharmaceuticals in Nuclear Medical Basic Information
Table 115. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Overview
Table 116. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Urenco Limited Business Overview
Table 118. Urenco Limited Recent Developments
Table 119. Rotem Industries Radiopharmaceuticals in Nuclear Medical Basic Information
Table 120. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Overview
Table 121. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Rotem Industries Business Overview
Table 123. Rotem Industries Recent Developments
Table 124. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Region (K Units)
Table 125. Global Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Region (M USD)
Table 126. North America Radiopharmaceuticals in Nuclear Medical Sales Forecast by Country (2022-2028) & (K Units)
Table 127. North America Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Country (2022-2028) & (M USD)
Table 128. Europe Radiopharmaceuticals in Nuclear Medical Sales Forecast by Country (2022-2028) & (K Units)
Table 129. Europe Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Country (2022-2028) & (M USD)
Table 130. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Forecast by Region (2022-2028) & (K Units)
Table 131. Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Region (2022-2028) & (M USD)
Table 132. South America Radiopharmaceuticals in Nuclear Medical Sales Forecast by Country (2022-2028) & (K Units)
Table 133. South America Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Country (2022-2028) & (M USD)
Table 134. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Country (2022-2028) & (Units)
Table 135. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Country (2022-2028) & (M USD)
Table 136. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Type (2022-2028) & (K Units)
Table 137. Global Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Type (2022-2028) & (M USD)
Table 138. Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Type (2022-2028) & (USD/Unit)
Table 139. Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) Forecast by Application (2022-2028)
Table 140. Global Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radiopharmaceuticals in Nuclear Medical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceuticals in Nuclear Medical Market Size (M USD), 2017-2028
Figure 5. Global Radiopharmaceuticals in Nuclear Medical Market Size (M USD) (2017-2028)
Figure 6. Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceuticals in Nuclear Medical Market Size (M USD) by Country (M USD)
Figure 11. Radiopharmaceuticals in Nuclear Medical Sales Share by Manufacturers in 2020
Figure 12. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers in 2020
Figure 13. Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Radiopharmaceuticals in Nuclear Medical Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceuticals in Nuclear Medical Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Radiopharmaceuticals in Nuclear Medical Market Share by Type
Figure 18. Sales Market Share of Radiopharmaceuticals in Nuclear Medical by Type (2017-2022)
Figure 19. Sales Market Share of Radiopharmaceuticals in Nuclear Medical by Type in 2021
Figure 20. Market Size Share of Radiopharmaceuticals in Nuclear Medical by Type (2017-2022)
Figure 21. Market Size Market Share of Radiopharmaceuticals in Nuclear Medical by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Radiopharmaceuticals in Nuclear Medical Market Share by Application
Figure 24. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2017-2022)
Figure 25. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2021
Figure 26. Global Radiopharmaceuticals in Nuclear Medical Market Share by Application (2017-2022)
Figure 27. Global Radiopharmaceuticals in Nuclear Medical Market Share by Application in 2020
Figure 28. Global Radiopharmaceuticals in Nuclear Medical Sales Growth Rate by Application (2017-2022)
Figure 29. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2017-2022)
Figure 30. North America Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country in 2020
Figure 32. U.S. Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Radiopharmaceuticals in Nuclear Medical Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country in 2020
Figure 37. Germany Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region in 2020
Figure 44. China Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (K Units)
Figure 50. South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country in 2020
Figure 51. Brazil Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Radiopharmaceuticals in Nuclear Medical Market Share Forecast by Type (2022-2028)
Figure 65. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2022-2028)
Figure 66. Global Radiopharmaceuticals in Nuclear Medical Market Share Forecast by Application (2022-2028)